Latest filing published 17 May 2017 for CorMedix Inc., €4,544.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -56.8%Entry US$2.20 · Close at T+365 US$0.95
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael W. George: trading record in brief
Filings by Michael W. George span 2 companies, the busiest being CURAXIS PHARMACEUTICAL Corp and CorMedix Inc. Over a trading history stretching from 10 October 2011 to 15 May 2017, the count stands at 4 filings.
The open-market record is one-sided, with 2 purchases worth €8,211 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. So far in 2017, the count stands at 1 purchase and no sales.
The newest entry dates from 17 May 2017: an open-market purchase of €4,544, in CorMedix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael W. George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.499100.0% of flowCommon StockSEC:0001354488-17-000514:0Canonical exit: 13 Aug 2017 (T+90)
- 200,000 shares@ US$0.04Common StockSEC:0001354488-12-000261:0
- 94,229 shares@ US$0.0849Common StockSEC:0001354488-11-004624:0
- 100,000 shares@ US$0.05Common StockSEC:0001354488-11-003750:0Canonical exit: 8 Jan 2012 (T+90)
4 of 4 declarations
